# Efficacy and Safety of Empagliflozin in Renal Transplant Recipients With Posttransplant Diabetes Mellitus

**Type:** Papers  
**Canonical URL:** https://scholariq.org/papers/efficacy-and-safety-of-empagliflozin-in-renal-transplant-recipients-with/

## Facts

| Field | Value |
| --- | --- |
| Author Names | Thea Anine Strøm Halden,Kine Eide Kvitne,Karsten Midtvedt,Laavanyaah Rajakumar,Ida Robertsen,Jan Brox,Jens Bollerslev,Anders Hartmann,Anders Åsberg,Trond Jenssen |
| Citations | 216 |
| DOI | 10.2337/dc19-0093 |
| Fields | Medicine |
| Open Access | true |
| OA Status | green |
| OA URL | http://hdl.handle.net/10852/76332 |
| OpenAlex ID | https://openalex.org/W2921909972 |
| PMID | 30862658 |
| Type | article |
| Year | 2019 |

## Paper authors

- [Jan Brox](https://scholariq.org/researchers/jan-brox/)

## Paper journal

- [Diabetes Care](https://scholariq.org/journals/diabetes-care/)

## Paper primary topic

- [Renal Transplantation Outcomes and Treatments](https://scholariq.org/topics/renal-transplantation-outcomes-and-treatments/)

## Paper topics

- [Renal Transplantation Outcomes and Treatments](https://scholariq.org/topics/renal-transplantation-outcomes-and-treatments/)
- [Diabetes Treatment and Management](https://scholariq.org/topics/diabetes-treatment-and-management/)
- [Pancreatic function and diabetes](https://scholariq.org/topics/pancreatic-function-and-diabetes/)

---
Source: ScholarIQ — public research metadata, principally OpenAlex. See https://scholariq.org/sources/ for provenance and https://scholariq.org/methodology/ for what these figures mean.